हमारा समूह 1000 से अधिक वैज्ञानिक सोसायटी के सहयोग से हर साल संयुक्त राज्य अमेरिका, यूरोप और एशिया में 3000+ वैश्विक सम्मेलन श्रृंखला कार्यक्रम आयोजित करता है और 700+ ओपन एक्सेस जर्नल प्रकाशित करता है जिसमें 50000 से अधिक प्रतिष्ठित व्यक्तित्व, प्रतिष्ठित वैज्ञानिक संपादकीय बोर्ड के सदस्यों के रूप में शामिल होते हैं।
ओपन एक्सेस जर्नल्स को अधिक पाठक और उद्धरण मिल रहे हैं
700 जर्नल और 15,000,000 पाठक प्रत्येक जर्नल को 25,000+ पाठक मिल रहे हैं
Alexander Lloyd Ng, Amanda Christina C. Dujua
Background and Aims: Neutropenic diet is still being used among cancer patients despite the lack of evidence of its benefit. Several studies showed lack of effectiveness of this regimen. However, most of these studies were done among adult patients. This meta-analysis analyzes the available data involving pediatric cancer patients who were placed on a neutropenic diet during chemotherapy.
Methods: A systematic search was conducted from April 2020 to October 2020 for randomized controlled trials investigating the effect of neutropenic diet versus regular diet among pediatric patients undergoing chemotherapy was done. Outcomes of interest were incidence of febrile neutropenia and bacteremia. A fixed-effects meta-analysis was done to pool the effect of intervention.
Results: A total of 269 patients were included. There was no statistically significant difference in the incidence of febrile neutropenia (RR 1.16, 95% CI 0.78 to 1.71) and bacteremia (RR 1.57, 95% CI 0.62 to 3.96) between the neutropenic diet and regular diet groups.
Conclusion: This meta-analysis showed that there is no evidence supporting the use of neutropenic diet in preventing febrile neutropenia and bacteremia among pediatric patients undergoing chemotherapy. Clinicians should be aware of the possible implications of applying this dietary regimen to pediatric cancer patients.